Lewis C. Cantley

Lewis C. Cantley (born February 20, 1949) is an American cell biologist and biochemist who has made significant advances to the understanding of cancer metabolism. Among his most notable contributions are the discovery and study of the enzyme PI-3-kinase, now known to be important to understanding cancer and diabetes mellitus. He is currently Meyer Director and Professor of Cancer Biology at the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine in New York City. He was formerly a professor in the Departments of Systems Biology and Medicine at Harvard Medical School, and the Director of Cancer Research at the Beth Israel Deaconess Medical Center, in Boston, Massachusetts.

Awards and honours

• ASBMB Avanti Award for Lipid Research (1998)
• Elected to the American Academy of Arts and Sciences (1999)
• Heinrich Wieland Prize for Lipid Research (2000)
• Elected to the National Academy of Sciences (2001)
• Caledonian Prize from the Royal Society of Edinburgh (2002)
• Pezcoller-AACR International Award for Cancer Research (2005)
• Rolf Luft Award of the Karolinska Institute (2009)
• Pasrow Prize for Cancer Research (2011)
• Breakthrough Prize in Life Sciences (2013)
• Jacobaeus Prize for Diabetes Research, from the Karolinska Institute (2013)
• Elected to the Institute of Medicine of the National Academies (2014)
• Ross Prize in Molecular Medicine (2015)
• Canada Gairdner International Award (2015)
• Elected to European life sciences academy EMBO (2015)
• The Association of American Cancer Institutes Distinguished Scientist Award (2015)
• The Wolf Prize (2015)